Cassava Sciences

URI: https://gptkb.org/entity/Cassava_Sciences
GPTKB entity
Statements (24)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:address 7801 N Capital of Texas Hwy, Suite 260, Austin, TX 78731, USA
gptkbp:CEO gptkb:Remi_Barbier
gptkbp:clinicalTrialPhase simufilam Phase 3 trials
gptkbp:country gptkb:United_States
gptkbp:focusesOn gptkb:Alzheimer's_disease
neurological diseases
gptkbp:formerName gptkb:Pain_Therapeutics,_Inc.
gptkbp:foundedYear 1998
gptkbp:founder gptkb:Remi_Barbier
gptkbp:headquartersLocation gptkb:Austin,_Texas,_United_States
https://www.w3.org/2000/01/rdf-schema#label Cassava Sciences
gptkbp:industry gptkb:biotechnology
gptkbp:listedOn gptkb:Russell_2000_Index
gptkbp:notableEvent subject of controversy regarding research data integrity
gptkbp:notableProduct gptkb:SavaDx
gptkb:simufilam
gptkbp:numberOfEmployees less than 50
gptkbp:publiclyTraded gptkb:NASDAQ
gptkbp:researchInterest drug development for Alzheimer's disease
gptkbp:stockSymbol gptkb:SAVA
gptkbp:website https://www.cassavasciences.com/
gptkbp:bfsParent gptkb:Pain_Therapeutics
gptkbp:bfsLayer 7